These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16521812)

  • 21. Hypertension and dementia.
    Nagai M; Hoshide S; Kario K
    Am J Hypertens; 2010 Feb; 23(2):116-24. PubMed ID: 19927134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertension and dementia: can antihypertensive treatment preserve cognitive function?
    Hansson L; Himmelmann A; Hedner T
    Blood Press; 1999; 8(4):196-7. PubMed ID: 10697297
    [No Abstract]   [Full Text] [Related]  

  • 23. Promising strategies for the prevention of dementia.
    Middleton LE; Yaffe K
    Arch Neurol; 2009 Oct; 66(10):1210-5. PubMed ID: 19822776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive and Functional Decline in Patients With Mild Alzheimer Dementia With or Without Comorbid Diabetes.
    Ascher-Svanum H; Chen YF; Hake A; Kahle-Wrobleski K; Schuster D; Kendall D; Heine RJ
    Clin Ther; 2015 Jun; 37(6):1195-205. PubMed ID: 25676448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular cognitive impairment. A preventable cause of dementia.
    Mayo Clin Womens Healthsource; 2008 Dec; 12(12):4-5. PubMed ID: 18985021
    [No Abstract]   [Full Text] [Related]  

  • 26. [Psychocognitive impairment evaluation in early post-stroke period].
    Naconecinîi D; Prodan MR; Leca-Radu E; Indrei A; Stefanache F
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(4):947-50. PubMed ID: 20209767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging.
    MacKnight C; Rockwood K; Awalt E; McDowell I
    Dement Geriatr Cogn Disord; 2002; 14(2):77-83. PubMed ID: 12145454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mental Demands at Work and Risk of Dementia.
    Sundström A; Sörman DE; Hansson P; Ljungberg JK; Adolfsson R
    J Alzheimers Dis; 2020; 74(3):735-740. PubMed ID: 32083580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the validity of deriving clinical dementia rating (CDR) global scores from independently-obtained functional rating scale (FRS) scores in vascular dementia with and without Alzheimer's disease.
    Lanctôt KL; Hsiung GY; Feldman HH; Masoud ST; Sham L; Herrmann N
    Int J Geriatr Psychiatry; 2009 Oct; 24(10):1174-6. PubMed ID: 19768698
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuropsychological correlates of behavioral symptoms in Alzheimer's disease, frontal variant of frontotemporal, subcortical vascular, and lewy body dementias: a comparative study.
    Perri R; Monaco M; Fadda L; Caltagirone C; Carlesimo GA
    J Alzheimers Dis; 2014; 39(3):669-77. PubMed ID: 24254701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular cognitive impairment in dementia.
    Etherton-Beer CD
    Maturitas; 2014 Oct; 79(2):220-6. PubMed ID: 25011396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular risk factors and dementia: how to move forward?
    Viswanathan A; Rocca WA; Tzourio C
    Neurology; 2009 Jan; 72(4):368-74. PubMed ID: 19171835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Early diagnosis and prevention of dementia in the aged].
    Hirai S
    Nihon Ronen Igakkai Zasshi; 1990 May; 27(3):305-9. PubMed ID: 2214306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors of dementia in North India: a case-control study.
    Tripathi M; Vibha D; Gupta P; Bhatia R; Srivastava MV; Vivekanandhan S; Bhushan Singh M; Prasad K; Dergalust S; Mendez MF
    Aging Ment Health; 2012; 16(2):228-35. PubMed ID: 21714688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease.
    Fischer CE; Qian W; Schweizer TA; Millikin CP; Ismail Z; Smith EE; Lix LM; Shelton P; Munoz DG
    J Alzheimers Dis; 2016; 50(1):283-95. PubMed ID: 26682680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychological syndromes associated with Alzheimer's/vascular dementia: a latent class analysis.
    Libon DJ; Drabick DA; Giovannetti T; Price CC; Bondi MW; Eppig J; Devlin K; Nieves C; Lamar M; Delano-Wood L; Nation DA; Brennan L; Au R; Swenson R
    J Alzheimers Dis; 2014; 42(3):999-1014. PubMed ID: 25024329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with resistance to dementia despite high Alzheimer disease pathology.
    Fotuhi M; Hachinski V; Kivipelto M; Whitehouse P
    Neurology; 2009 Nov; 73(19):1607; author reply 1607-8. PubMed ID: 19901259
    [No Abstract]   [Full Text] [Related]  

  • 38. The possibility of vascular care for prevention of dementia.
    Morita T; Higuchi A; Ozaki A; Shimada Y; Tanimoto T
    Lancet; 2017 Jan; 389(10065):152-153. PubMed ID: 28102135
    [No Abstract]   [Full Text] [Related]  

  • 39. No evidence for cognitive improvement from oral nicotinamide adenine dinucleotide (NADH) in dementia.
    Rainer M; Kraxberger E; Haushofer M; Mucke HA; Jellinger KA
    J Neural Transm (Vienna); 2000; 107(12):1475-81. PubMed ID: 11459000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human-figure drawing (HFD) in the screening of cognitive impairment in old age.
    Ericsson K; Hilleräs P; Holmén K; Winblad B
    J Med Screen; 1996; 3(2):105-9. PubMed ID: 8849770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.